U.S., July 19 -- ClinicalTrials.gov registry received information related to the study (NCT07073014) titled 'Long-Term Extension Study of Vosoritide to Treat Children With Hypochondroplasia' on June 27.
Brief Summary: The purpose of this study is to evaluate the long-term safety and efficacy of daily doses of vosoritide in participants with HCH
Study Start Date: June 20
Study Type: INTERVENTIONAL
Condition:
Hypochondroplasia
Intervention:
DRUG: Vosoritide
Open-label administration of vosoritide using weight-band dosing
Recruitment Status: ENROLLING_BY_INVITATION
Sponsor: BioMarin Pharmaceutical
Published by HT Digital Content Services with permission from Health Daily Digest....